Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-23-018866

Options or other derivatives

  • Director acquired 6,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Soteropoulos Paula Director 2023-09-11 Grant or award · Stock Option (Right to Buy) +6,500 6,500 D
Loading xslF345X05/doc4.xml…